Skip to main content
SpringerLink
Log in

Molecular Carcinogenesis of Glial Brain Tumors

  • Chapter
  • First Online:
Mechanisms of Molecular Carcinogenesis – Volume 1

  • 723 Accesses

Abstract

Glial tumors represent the most common primary central nervous system tumors. They are classified as astrocytomas, oligodendrogliomas, and oligoastrocytomas. They may occur as benign tumors (WHO grade II) or anaplastic tumors (WHO grade III). The most malignant astrocytoma is called glioblastoma and represents WHO grade IV.

With the recent publication of the revised fourth edition of the WHO classification of CNS tumors, the molecular characterization of the tumors becomes mandatory. Elementary investigations include the determination of the mutation status of IDH1/2 and co-deletion of 1p/19q. Additional parameters include mutations in the ATRX gene and the TERT promoter. A variety of genetic alterations have been described. Specific focus was laid on epigenetic changes, i.e., altered methylation patterns. Studies related to gene or microRNA (miR) expression in brain tumors are still scarce. Brain tumors pose a challenging task for the clinician and require further broad-minded molecular investigations at various levels.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Ostrom QT, Gittleman H, Farah P, Ondracek A, Chen Y, Wolinsky Y, Stroup NE, Kruchko C, Barnholtz-Sloan JS. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2006-2010. Neuro Oncol. 2013;15(Suppl 2):ii1–56. doi:10.1093/neuonc/not1151.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Ostrom QT, Gittleman H, Fulop J, Liu M, Blanda R, Kromer C, Wolinsky Y, Kruchko C, Barnholtz-Sloan JS. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008-2012. Neuro Oncol. 2015;17(Suppl 4):iv1–iv62. doi:10.1093/neuonc/nov1189.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Ostrom QT, Gittleman H, Liao P, Rouse C, Chen Y, Dowling J, Wolinsky Y, Kruchko C, Barnholtz-Sloan J. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. Neuro Oncol. 2014;16(Suppl 4):iv1–63. doi:10.1093/neuonc/nou1223.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Ellison DW, Figarella-Branger D, Perry A, Reifenberger G, Von Deimling A. WHO classification of tumours of the central nervous system. Revised 4th ed. Lyon: WHO/IARC; 2016.

    Google Scholar 

  5. Rodriguez FJ, Vizcaino MA, Lin MT. Recent advances on the molecular pathology of glial neoplasms in children and adults. J Mol Diagn. 2016;18(5):620–34. doi:10.1016/j.jmoldx.2016.1005.1005.

    Article  CAS  PubMed  Google Scholar 

  6. Yan H, Parsons DW, Jin G, McLendon R, Rasheed BA, Yuan W, Kos I, et al. IDH1 and IDH2 mutations in gliomas. N Engl J Med. 2009;360(8):765–73. doi:10.1056/NEJMoa0808710.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Watson LA, Goldberg H, Berube NG. Emerging roles of ATRX in cancer. Epigenomics. 2015;7(8):1365–78. doi:10.2217/epi.1315.1382.

    Article  CAS  PubMed  Google Scholar 

  8. Killela PJ, Reitman ZJ, Jiao Y, Bettegowda C, Agrawal N, Diaz Jr LA, Friedman AH, et al. TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal. Proc Natl Acad Sci U S A. 2013;110(15):6021–6. doi:10.1073/pnas.1303607110.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Koelsche C, Sahm F, Capper D, Reuss D, Sturm D, Jones DT, Kool M, et al. Distribution of TERT promoter mutations in pediatric and adult tumors of the nervous system. Acta Neuropathol. 2013;126(6):907–15. doi:10.1007/s00401-00013-01195-00405.

    Article  CAS  PubMed  Google Scholar 

  10. Jiao Y, Killela PJ, Reitman ZJ, Rasheed AB, Heaphy CM, de Wilde RF, Rodriguez FJ, et al. Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas. Oncotarget. 2012;3(7):709–22.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Bleeker FE, Molenaar RJ, Leenstra S. Recent advances in the molecular understanding of glioblastoma. J Neurooncol. 2012;108(1):11–27. doi:10.1007/s11060-11011-10793-11060.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Dunn GP, Rinne ML, Wykosky J, Genovese G, Quayle SN, Dunn IF, Agarwalla PK, et al. Emerging insights into the molecular and cellular basis of glioblastoma. Genes Dev. 2012;26(8):756–84. doi:10.1101/gad.187922.187112.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, Miller CR, et al. An integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR and NF1. Cancer Cell. 2010;17(1):98.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Lueth M, Wronski L, Giese A, Kirschner-Schwabe R, Pietsch T, von Deimling A, Henze G, Kurtz A, Driever PH. Somatic mitochondrial mutations in pilocytic astrocytoma. Cancer Genet Cytogenet. 2009;192(1):30–5. doi:10.1016/j.cancergencyto.2009.1003.1002.

    Article  CAS  PubMed  Google Scholar 

  15. Moller HG, Rasmussen AP, Andersen HH, Johnsen KB, Henriksen M, Duroux M. A systematic review of microRNA in glioblastoma multiforme: micro-modulators in the mesenchymal mode of migration and invasion. Mol Neurobiol. 2013;47(1):131–44. doi:10.1007/s12035-12012-18349-12037.

    Article  CAS  PubMed  Google Scholar 

  16. Birks DK, Barton VN, Donson AM, Handler MH, Vibhakar R, Foreman NK. Survey of MicroRNA expression in pediatric brain tumors. Pediatr Blood Cancer. 2011;56(2):211–6. doi:10.1002/pbc.22723.

    Article  PubMed  Google Scholar 

  17. Bredel M, Scholtens DM, Harsh GR, Bredel C, Chandler JP, Renfrow JJ, Yadav AK, et al. A network model of a cooperative genetic landscape in brain tumors. JAMA. 2009;302(3):261–75. doi:10.1001/jama.2009.1997.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Colman H, Zhang L, Sulman EP, McDonald JM, Shooshtari NL, Rivera A, Popoff S, et al. A multigene predictor of outcome in glioblastoma. Neuro Oncol. 2010;12(1):49–57. doi:10.1093/neuonc/nop1007.

    Article  CAS  PubMed  Google Scholar 

  19. de Tayrac M, Aubry M, Saikali S, Etcheverry A, Surbled C, Guenot F, Galibert MD, et al. A 4-gene signature associated with clinical outcome in high-grade gliomas. Clin Cancer Res. 2011;17(2):317–27. doi:10.1158/1078-0432.CCR-1110-1126.

    Article  PubMed  Google Scholar 

  20. Marko NF, Weil RJ. The molecular biology of WHO Grade II gliomas. Neurosurg Focus. 2013;34(2):E1. doi:10.3171/2012.3112.FOCUS12283.

    Article  PubMed  Google Scholar 

  21. Ohgaki H, Kleihues P. Genetic profile of astrocytic and oligodendroglial gliomas. Brain Tumor Pathol. 2011;28(3):177–83. doi:10.1007/s10014-10011-10029-10011.

    Article  CAS  PubMed  Google Scholar 

  22. Riemenschneider MJ, Reifenberger G. Astrocytic tumors. In: von Deimling A, editor. Gliomas, Recent results cancer res, vol. 171. Berlin: Springer; 2009. p. 3–24.

    Chapter  Google Scholar 

  23. Sarkar C, Jain A, Suri V. Current concepts in the pathology and genetics of gliomas. Indian J Cancer. 2009;46(2):108–19.

    Article  CAS  PubMed  Google Scholar 

  24. Gupta K, Salunke P. Molecular markers of glioma: an update on recent progress and perspectives. J Cancer Res Clin Oncol. 2012;138(12):1971–81. doi:10.1007/s00432-00012-01323-y.

    Article  CAS  PubMed  Google Scholar 

  25. Martinez R. Beyond genetics in glioma pathways: the ever-increasing crosstalk between epigenomic and genomic events. J Signal Transduct. 2012;2012:519807.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Ohgaki H, Kleihues P. Genetic pathways to primary and secondary glioblastoma. Am J Pathol. 2007;170(5):1445–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Purow BW, Schiff D. Glioblastoma genetics: in rapid flux. Discov Med. 2010;9(45):125–31.

    PubMed  PubMed Central  Google Scholar 

  28. Westermark B. Glioblastoma--a moving target. Ups J Med Sci. 2012;117(2):251–6. doi:10.3109/03009734.03002012.03676574.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Marko NF, Weil RJ. The molecular biology of WHO grade I astrocytomas. Neuro Oncol. 2012;14(12):1424–31. doi:10.1093/neuonc/nos1257.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Pfister S, Witt O. Pediatric gliomas. In: von Deimling A, editor. Gliomas, Recent results cancer res, vol. 171. Berlin: Springer; 2009. p. 67–81.

    Chapter  Google Scholar 

  31. Alentorn A, Sanson M, Idbaih A. Oligodendrogliomas: new insights from the genetics and perspectives. Curr Opin Oncol. 2012;24(6):687–93. doi:10.1097/CCO.1090b1013e328357f328354ea.

    Article  CAS  PubMed  Google Scholar 

  32. Harris BT, Hattab EM. Molecular pathology of the central nervous system. In: Cheng L, Eble JN, editors. Molecular surgical pathology. New York, NY: Springer Science+Business Media; 2013. p. 357–405.

    Chapter  Google Scholar 

  33. Hartmann C, von Deimling A. Molecular pathology of oligodendroglial tumors. In: von Deimling A, editor. Gliomas, Recent results cancer res, vol. 171. Berlin: Springer; 2009. p. 25–49.

    Chapter  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory of Molecular Biology, Department of Laboratory Medicine, Christian Doppler University Hospital, Paracelsus Medical University, Salzburg, Austria

    Peter Strasser

  2. Department of Neuropathology, Neuromed Campus, Kepler University Hospital, School of Medicine, Johannes Kepler University, Linz, Austria

    Serge Weis

Authors
  1. Peter Strasser
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Serge Weis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Serge Weis .

Editor information

Editors and Affiliations

  1. Department of Pathology, Medical Faculty, Otto von Guericke University Magdeburg, Magdeburg, Germany

    Johannes Haybaeck

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Strasser, P., Weis, S. (2017). Molecular Carcinogenesis of Glial Brain Tumors. In: Haybaeck, J. (eds) Mechanisms of Molecular Carcinogenesis – Volume 1. Springer, Cham. https://doi.org/10.1007/978-3-319-53659-0_7

Download citation

Publish with us

Policies and ethics

Search

Navigation